Wienholt, Patrick
Kuhl, Christiane
Kather, Jakob Nikolas
Nebelung, Sven
Truhn, Daniel
Funding for this research was provided by:
RWTH Aachen University
Article History
Received: 18 September 2025
Accepted: 12 February 2026
First Online: 20 February 2026
Declarations
:
: D.T. received honoraria for lectures by Bayer, GE, Roche, Astra Zenica, and Philips and holds shares in StratifAI GmbH, Germany and in Synagen GmbH, Germany. J.N.K. declares consulting services for Panakeia, AstraZeneca, MultiplexDx, Mindpeak, Owkin, DoMore Diagnostics, and Bioptimus. Furthermore, he holds shares in StratifAI, Synagen, Tremont AI, and Ignition Labs, has received an institutional research grant from GSK, and has received honoraria from AstraZeneca, Bayer, Daiichi Sankyo, Eisai, Janssen, Merck, MSD, BMS, Roche, Pfizer, and Fresenius.